Mohammad Athar | Forensic Science | Excellence in Innovation Award

Posted on by Phenomenological Research Awards

Dr. Mohammad Athar | Forensic Science | Excellence in Innovation Award 

Assistant Professor & Founder Member at Institute for Excellence in Higher Education Bhopal |India

Dr. Mohammad Athar is a distinguished forensic science researcher whose work spans forensic biochemistry, medico-legal investigation, biomarker studies, food toxicology, and advanced analytical instrumentation. His contributions demonstrate a strong commitment to advancing forensic methodologies through innovative applications of FTIR, HPLC, HPTLC, and micellar liquid chromatography. Dr. Mohammad Athar has conducted impactful research on detecting non-permitted food dyes, identifying toxic chemicals, exploring saliva-based biomarkers for oral cancer, and enhancing forensic investigation techniques. His scholarly output reflected in 42 citations, an h-index of 3, and an i10-index of 2 shows a growing influence in forensic science and interdisciplinary research. He has published widely across national and international journals, contributed several book chapters, and actively reviewed scientific manuscripts. Dr. Mohammad Athar has also played significant roles in academic leadership, curriculum development, and the organization of global scientific conferences. His work in forensic education, analytical method development, and knowledge dissemination underscores his innovative approach and dedication to strengthening forensic science as a discipline. Through continuous research, teaching excellence, and service to scientific communities, Dr. Mohammad Athar exemplifies innovation and scholarly impact within the field of forensic science.

Profile: Google Scholar | Linkedin

Featured Publications:

Athar, M. (2020). Understanding about viruses: Alive or not? Virology and Mycology, 9(3), 2.

Athar, A. M. (2020). Trace evidence: A versatile key in forensic investigation. International Journal of Forensic Sciences, 5(2).

Athar, M. (2020). Truth about dates: Good for your health. Food Science & Nutrition Technology, 5(3).

Athar, A. M. (2020). Truth about Coronavirus (COVID-19). Open Access Journal of Pulmonary & Respiratory Sciences, 5(1).

Athar, A. M. (2020). A versatile tool: Alternative light source (ALS) in forensic investigation. International Journal of Forensic Sciences, 5(2).

Athar, M. (2020). Truth about bats: Transmit so many viruses. Virology & Immunology Journal, 4(1).

Athar, A. M. (2020). Detrimental effects of perfumes, aroma & cosmetics. Dermatology & Cosmetology, 4(2).

Athar, A. M. (2020). Current circumstances of Coronavirus (COVID-19) in India. International Archives of Public Health and Community Medicine, 4(2).

Athar, M. (2020). A versatile tool: Alternative light source (ALS) in forensic investigation. INTERNATIONAL JOURNAL, 5(2).

Rolf Teschke | Medicine and Dentistry | Best Paper Award

Posted on by Phenomenological Research Awards

Prof. Rolf Teschke | Medicine and Dentistry | Best Paper Award

Professor at Klinikum Hanau | Germany

Prof. Rolf Teschke is an internationally recognized expert in hepatology whose distinguished career has significantly influenced contemporary understanding of liver diseases, hepatotoxicity, and drug-induced liver injury. Educated at leading medical institutions and trained in internal medicine with specialization in gastroenterology and hepatology, he advanced early in his career through rigorous scientific and clinical environments that shaped his enduring interest in hepatic metabolism and toxicology. His research journey includes extensive work in experimental hepatology, where he contributed pivotal insights into microsomal ethanol-oxidizing systems, cytochrome P450 related pathways, and the biochemical mechanisms underlying alcohol-associated and toxin-induced liver damage. Over several decades, Prof. Rolf Teschke has held prominent academic and clinical positions, leading major medical departments and contributing to both patient care and research innovation. His expertise is particularly well known for advancing causality assessment methodologies in drug-induced liver injury, especially through his influential work with the RUCAM system, which has become a globally referenced tool in hepatotoxicity evaluation. Throughout his career, he has produced a substantial body of peer-reviewed literature, reflecting profound scientific productivity and impact. His publication record includes 171 documents, supported by 6,888 citations across 4,040 citing documents, and an impressive h-index of 48, underscoring the depth, relevance, and international recognition of his work. Prof. Rolf Teschke’s research interests span alcoholic liver disease, herbal and drug hepatotoxicity, biochemical enzymology, and clinical hepatology, integrating laboratory discoveries with real-world clinical applications to improve diagnostic standards and therapeutic strategies. He has authored and co-authored more than 250 publications, including articles, book chapters, and comprehensive reviews, contributing to foundational knowledge used by clinicians, toxicologists, and regulatory bodies worldwide. In addition to research, he has served in editorial roles for several journals, helping guide scientific discourse in hepatology and liver toxicology. Overall, Prof. Rolf Teschke’s career reflects a sustained commitment to advancing scientific excellence, improving patient outcomes, and shaping global best practices in the study of liver injury, marking him as one of the leading contributors to modern hepatology.

Profile; Scopus | Orcid

Featured Publications:

Teschke, R. Drug-Induced Autoimmune Hepatitis by Varenicline and Infliximab as a Continuous Disease Spectrum with Two Different Flares: Acute Liver Injury Followed by Hepatic Autoimmunity. Review.
Annotation: Discusses two-step autoimmune hepatitis triggered by pharmaceutical agents, highlighting diagnostic and clinical implications.

Teschke, R. Acute Liver Failure with Determinate rather than Indeterminate Etiology Facilitates Therapy and May Avoid Liver Transplantation: A Critical Analysis. Review.
Annotation: Evaluates clinical outcomes in acute liver failure and argues the benefits of precise etiological identification.

Teschke, R., et al. Drug-Induced Autoimmune Hepatitis: Robust Causality Assessment Using Two Different Validated and Scoring Diagnostic Algorithms. Review.
Annotation: Compares two validated diagnostic algorithms to strengthen causality assessment in drug-induced autoimmune hepatitis.

Teschke, R. Immunology Highlights of Four Major Idiosyncratic DILI Subtypes Verified by the RUCAM: A New Evidence-Based Classification. Review.
Annotation: Proposes an evidence-based immunological classification for idiosyncratic drug-induced liver injury (DILI).

Teschke, R., et al. Metabolic Mysteries of Copper Dysregulation in Wilson Disease. Review.
Annotation: Explores metabolic pathways and unresolved mechanisms underlying copper dysregulation in Wilson’s disease.

Teschke, R., et al. Open Questions on How Metabolic Dysfunction-Associated Steatotic Liver Disease Shapes the Course of Drug-Induced Liver Injury. Letter.
Annotation: Raises key unresolved scientific and clinical questions on the interaction between MASLD and DILI.

Teschke, R. Liver Injury in Immune Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Five New Classification Types. Review.
Annotation: Introduces a new five-type classification system for liver injury associated with severe immune-mediated skin reactions.

Teschke, R. Acute Liver Failure Due to Assumed Drug Induced Liver Injury but Lack of Any Validated Causality Algorithm: Evidence by 36 Cohort Reports with 21,709 Cases. Review.
Annotation: Critically analyzes large cohorts revealing gaps in validated causality assessment for assumed DILI-related acute liver failure.

Teschke, R. Idiosyncratic Hepatocellular Drug-Induced Liver Injury by Flucloxacillin with Evidence Based on RUCAM and HLA B57:01 Genotype.* Review.
Annotation: Examines metabolic and immune mechanisms underlying flucloxacillin-induced hepatocellular injury.

Teschke, R., et al. Successful Corticosteroid Therapy for Severe Liver Injury Secondary to Herbal Traditional Chinese Medicine Mega Defends X: A Case Report. Article, 2024.
Annotation: Documents a clinically significant case showing steroid responsiveness in herb-induced liver injury assessed by updated RUCAM.

Essa. M. Saied | Pharmacology | Research Excellence Award

Posted on by Phenomenological Research Awards

Assoc. Prof. Dr. Essa.M. Saied | Pharmacology | Research Excellence Award 

Associate Prof. Dr at Humboldt Universität zu Berlin | Germany

Assoc. Prof. Dr. Essa M. Saied is an accomplished scholar whose work spans pharmacology, bioorganic chemistry, and medicinal chemistry, contributing significantly to contemporary drug discovery and therapeutic innovation. His scholarly influence is demonstrated by 2,229 citations across 1,535 documents, 72 published works, and an h-index of 31, reflecting strong global recognition. Assoc. Prof. Dr. Essa M. Saied’s academic trajectory includes rigorous training in chemistry, culminating in advanced graduate studies with a specialization in organic and bioorganic chemistry, where he developed a solid foundation in molecular design, synthetic methodologies, and biochemical mechanisms. His professional journey includes progressive roles in academic and research institutions, where he has contributed to pioneering studies on small-molecule drug development, high-throughput screening, lipid biochemistry, heterocyclic chemistry, and the structural biology of disease-related enzymes. He has collaborated with multidisciplinary teams in developing chemical probes, enzymatic assays, and computational models, integrating experimental and in silico approaches to accelerate drug discovery pipelines. Assoc. Prof. Dr. Essa M. Saied’s research interests encompass synthetic medicinal chemistry, lipid metabolism, molecular modelling, virtual screening, anticancer agents, antiviral strategies, and the mechanistic understanding of bioactive metabolites in human disease. His publications in top-tier journals, including Nature, Angewandte Chemie, Nature Communications, PNAS, and Developmental Cell, highlight the depth and impact of his contributions. In addition to his research achievements, he has been actively involved in scientific reviewing, editorial roles, and mentorship, supporting the professional growth of emerging researchers and contributing to the quality and integrity of scientific publishing. His work bridges fundamental chemical sciences and applied biomedical research, enabling the translation of molecular insights into potential therapeutic strategies. Assoc. Prof. Dr. Essa M. Saied’s continuing efforts aim to expand the frontiers of pharmacological science through innovative chemical tools, mechanistic exploration of lipid pathways, and the development of novel drug candidates. In conclusion, Assoc. Prof. Dr. Essa M. Saied stands as a leading figure in his field, recognized for his impactful research, broad expertise, and sustained commitment to advancing scientific knowledge for global health benefit.

Profile: Scopus | Orcid | Google Scholar | Researchgate

Featured Publications:

1.Saied, E. M., et al. (2025). Synthesis and multi-target antiproliferative evaluation of novel 1,2,4-triazole-3-thione analogues against breast cancer: In silico and in vitro mechanistic insights. RSC Advances.

2.Saied, E. M., et al. (2025). Exploration of the anticancer efficacy of a novel 1,3-thiazole analog in an Ehrlich ascites carcinoma model: In vivo and in silico insights into hepatorenal protective potentials via modulation of apoptosis, oxidative stress and inflammation. RSC Advances.

3.Saied, E. M., et al. (2025). Mapping stress memory: Genetic and epigenetic insights into combined drought and heat tolerance in barley. Plant Cell Reports.

4.Saied, E. M., et al. (2025). Candidate gene discovery for the biofortification of wheat grains with essential micronutrients for global food security. Cereal Research Communications.

5.Saied, E. M., et al. (2025). Multi-targeted azacoumarin–cyanocinnamate hybrids induce G2/M arrest and apoptosis via tubulin and COX-2/VEGFR modulation: Insights from in vitro mechanistic basis and in vivo validation. RSC Medicinal Chemistry.

6.Saied, E. M., et al. (2025). Editorial: Medicinal chemistry for neglected tropical diseases using in vitro, in vivo, and in silico approaches. [Journal Name Not Provided].

7.Saied, E. M., et al. (2024). Live-cell identification of inhibitors of the lipid transfer protein CERT using nanoluciferase bioluminescence resonance energy transfer (NanoBRET). Angewandte Chemie International Edition.

Nahida Akhter | Nursing and Health Professions | Best Researcher Award

Posted on by Phenomenological Research Awards

Mrs. Nahida Akhter | Nursing and Health Professions | Best Researcher Award 

PhD Student at Hiroshima University | Japan

Mrs. Nahida Akhter is a dedicated nursing scholar whose work reflects a strong commitment to advancing critical care practice, nursing education, and evidence-informed decision-making in global health systems. As a researcher deeply engaged with the principles of Evidence-Based Practice (EBP), she focuses on strengthening the capacity of nurses to integrate research evidence into clinical workflows, particularly within intensive care settings where timely, informed decisions are essential for improving patient outcomes. Her academic journey spans foundational nursing qualifications through advanced graduate studies, providing her with a solid theoretical base and research orientation that supports her current scholarly contributions. Over the course of her career, Mrs. Akhter has accumulated extensive experience across critical care nursing, clinical leadership, healthcare training, and professional development initiatives. She has served in roles involving ICU practice, organizational planning, healthcare workforce development, and national-level program implementation, allowing her to gain meaningful insight into both clinical challenges and systemic needs in the nursing profession. Her active engagement in academic conferences, professional societies, and research collaborations reflects her ongoing commitment to innovation and knowledge dissemination. Mrs. Akhter’s research interests include evidence-based nursing, critical care practice, clinical decision-making, patient safety, infection control, nursing curriculum improvement, and strengthening health systems in resource-constrained environments. She is particularly motivated by the need to reduce gaps between research and practice, with a vision of empowering nurses to deliver high-quality care grounded in scientific evidence and reflective practice. Her scholarly work aligns with global efforts to enhance healthcare quality and develop resilient nursing systems capable of responding to evolving clinical demands. Through her research, leadership, and professional service, Mrs. Nahida Akhter continues to contribute to the advancement of nursing as both a science and a practice. She remains committed to fostering a culture of continuous learning, supporting the professional growth of nursing personnel, and promoting evidence-based care models that improve outcomes for diverse patient populations. This ongoing dedication underscores her role as an influential contributor to the field and a strong advocate for strengthening the future of nursing worldwide.

Profile: Orcid

Featured Publications:

Akhter, N. (2025, November 2). Evidence-Based Practices to Prevent Ventilator-Associated Pneumonia in an Intensive Care Unit in Bangladesh. Healthcare.

Akhter, N. (2025, November 8). Effect of EBP Training for Prevention of Ventilator-Associated Pneumonia in ICU of Bangladesh. Conference paper presented at the 48th Biennial Convention of Sigma.

Akhter, N. (2025, June 11). Presenter. Conference paper presented at the ICN Helsinki Conference 2025.

Akhter, N. (2024). Presenter. 3 Zero Competition, Conference presentation.

Akhter, N. (2024, October 28). Presenter. Conference paper presented at the IWCA Annual Fall Conference 2024.

Akhter, N. (2024, August 28). Presenter. Conference paper presented at the Social Tech Conference 2024.